This contract expires in 366 days (Sep 14, 2027).

Browse related active opportunities

LOYOLA UNIVERSITY OF CHICAGO - MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS

PIID: 75N98026P01477
Signed Date: Sep 8, 2026Effective Date: Sep 15, 2026End Date: Closes in 366 days
Award $
$350K
Vendor
LOYOLA UNIVERSITY OF CHICAGO
NAICS
622110
Signed Date
Sep 8, 2026

Key Details

Dollars Obligated
$350,000
Awarding Sub-Agency
National Institutes of Health
Product Service Code
R499 - SUPPORT- PROFESSIONAL: OTHER
Place of Performance
MAYWOOD, IL

Description

MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS

Context & Analysis

On Sep 8, 2026, Department of Health and Human Services obligated $350,000 to LOYOLA UNIVERSITY OF CHICAGO for modification to the a11 herv-e tcr and t cell product toimprove the therapeutic efficacy for ccrcc patients. The award is classified under NAICS 622110 — GENERAL MEDICAL AND SURGICAL HOSPITALS. Performance is located in MAYWOOD, IL. The contract is scheduled through Sep 14, 2027 — approximately 12 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 622110 — related awards are listed below.

Contractor Information

UEI: RFRPFMNR8LA5
Location: MAYWOOD, IL

Stay Updated

Get notified about new opportunities matching your interests.

Related